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    INTRODUCTION 
  Systemic  Inflammatory  Response  Syndrome  (SIRS)  is  an  
inflammatory condition  which  affects   multiple  systems in the  body  and  
often occurs  as  a  response  which is immunologically mediated  by  the  
protective  immune system to  infectious agent. SIRS  is closely  associated 
with  sepsis,  a state  wherein  the  patients  satisfy   the  criteria  for  systemic  
inflammatory  response  syndrome and  also when its  etiology  is  suspected  
to  be  of  infectious  nature. Systemic  inflammatory  response syndrome  is  a  
critical state  and  is  associated  with  systemic  inflammatory  response , 
multiple  organ injury  and  organ failure.  
Definition 
Systemic inflammatory response syndrome 
Finding Value 
Temperature <36 °C (96.8 °F) or >38 °C (100.4 °F) 
Heart rate >90/min 
Respiratory rate >20/min or PaCO2<32 mmHg (4.3 kPa) 
WBC count. 
<4x109/L (<4000/mm³) or >12x109/L (>12,000/mm³), 
or >10% bands 
 
Two or more of the above clinical or laboratory findings should be 
present to make a diagnosis of SIRS and may have a non infectious cause. 
Magnesium  plays a  vital role  in sepsis  and  systemic  inflammatory 
response  syndrome  (SIRS)  especially  in seriously  decompensated    
patients  in  the   intensive  medical  care  unit10.  Hypomagnesemia  has  been  
found to be associated with progression  towards occurrence  of  functional 
impairment of multiple  organs  and  systemic  inflammatory  response  
syndrome  in  patients treated in Intensive medical care unit38.  Magnesium 
deficiency  leads  on to  aggravated  production  of  cytokines  which  favour  
inflammation. Also production  of  endothelins  is  increased.   
In certain  experiments  related  to  sepsis  it  was demonstrated  that 
there  is  aggravated  mortality  in the  setting  of  ongoing  magnesium  
depletion or  deficiency  and  administration of  magnesium  supplements  may  
have  a  protective  response  on challenge  with  endotoxins 31,32,33 .  The  
effect  was  owing  to  the  fact  that  there  was decreased  production  of  
cytokines  which  are  favouring  inflammatory response  in  the system. These  
cytokines  are Tumor  necrosis factor alpha  and  Interleukin 6 . 
  
Magnesium  deficiency  has been  reported  in  individuals  afflicted  
with a wide  spectrum of  different  disease states which  comprise infectious  
diseases like cerebral malaria, multi  drug  resistant malaria, leptospirosis, 
tetanus, kidney related  sepsis  and  infections, cellulitis, meningoencephalitis, 
lung  parenchymal  infections, pulmonary  tuberculosis  and  invasive  
aspergillosis, hepatic  encephalopathy, acute  fulminant  hepatitis  or  cirrhosis,  
acute  kidney  injury  due  to intravascular  volume  depletion and septicaemia, 
pre-existing   kidney  disease, respiratory  decompensation   due to  chronic  
obstructive  pulmonary  disease,  lung  involvement  as in ILD  and  acute 
respiratory distress syndrome , heart  failure due to  coronary  artery  disease  
or  other  valvular  pathology,  cerebrovascular  injury due  to  cerebrovascular  
ischemia  or hemorrhage, snake bite  related  sepsis  and  poisonings for  
example  OPC  compounds  and  drug  overdosage37. 
Many  factors  lead  on   to   magnesium  depletion  in seriously 
decompensated individuals  admitted  to  ICU   like  decreased  assimilation of 
magnesium, nasogastric  aspiration,  lack  of  adequate  amount of the nutrient   
in  certain feeding  formulations  or  Total Parenteral Nutrition  compounds, 
use  of certain medicines like  diuretics, gentamycin, amikacin , and  
amphotericin-B  which  leads  on to the  loss of this vital  mineral  through  the  
kidneys. 
Hypermagnesemia  is  observed  less frequently in clinical  practice  and  
it  may be   due  to  iatrogenic  or kidney diseases 37. Magnesium  depletion in  
the  system   has  been found to present  with  a  wide variety  of  clinical 
features such as ventricular and atrial  tachycardias, heart failure,  coronary 
artery constriction, unexpected  cardiac mortality,  certain skeletal and 
respiratory  muscle  decompensation, broncho constriction, convulsions, and  
also  certain other  neurologic manifestations and  a  wide spectrum of  
associated   electrolyte  disturbances like deficiency  of potassium  calcium 
,sodium  and  phosphate36. 
Hypomagnesemia  is  supposed  to  be  one  among   the  frequently 
encountered   electrolyte abnormalities seen  among  the   ICU  patients37. Also  
hypomagnesemia  has  been  found  to  be  related   to  increased  duration  of  
hospital  stay  and  30 day  mortality5,17,37. It  is  also associated  with  
increased  possibility  of  respiratory  failure  and  mechanical ventilation  in  
ICU  patients  with  sepsis  and  SIRS  and  increased  duration of  stay  under  
mechanical  ventilatory  support28,29,30. 
The  present  study  was  undertaken  with  the  aim  of  estimating  
serum magnesium  levels  in  the  patients  who undergo  treatment in   the  
medical intensive care unit   satisfying  the diagnostic  criteria  for  systemic 
inflammatory response syndrome and  to  assess  the  clinical  outcome  in  
these  patients  with relation   to  the  serum magnesium  levels.The  clinical  
progress  is  aimed  to  be  assessed  in  patients  with  low  magnesium  levels  
duration  of   ICU stay, need  for  ventilator  support  and  its  outcome, and  
mortality  rate. 
  
AIM OF THE STUDY 
        The aim of this study is                                 
1. Estimating  serum  magnesium  concentrations  in  patients  with  
Systemic Inflammatory  Response  Syndrome   (SIRS)  in  the  medical  
ICU . 
2.  Correlating  serum  magnesium  concentrations  with  prognosis  
of  SIRS  patients. 
3. To  assess  the  clinical  outcome  in  patients  found  to  have  abnormal 
magnesium  levels in  relation  to  duration  of  ICU  stay, mortality  
rate, need  for  mechanical  ventilation  and  duration  of  ventilator  
support. 
4. To  analyse  the  other  clinical  and  biochemical  data  obtained  during  
the study  in  SIRS  patients  and  to  arrive  at  conclusions. 
 
                                           
 
 
 
    
REVIEW OF LITERATURE 
                                       
MAGNESIUM 
 Magnesium  is  an essential  divalent  cation found  in the cell20. It  is  
crucial  in  the normal  neuromuscular  activity of  human  body . The 
magnesium found inside the cell forms  an  essential  ATP  bound complex   
and  is  a  vital  cofactor  in a spectrum of different  enzymes, nucleic  acids 
and  transporters  required  for  normal  cellular  function, replication  &  
energy  metabolism11,20.  Normal  range  of  serum  magnesium  is maintained  
within the  range  of  1.5- 2  meq/L  or  (1.7-2.4 mg/dl) . 30%  of  this 
magnesium  is  protein  bound  &  15 %  is  bound  to  phosphate. 
 50 %  of  the  total  body magnesium  is  located  in  bone,  &  only   one 
half  is  insoluble  in  mineral  phase. Most  of  the  extraskeletal  magnesium  
is present  within  the  cells, and  the  total  concentration is 5 mM &  95%  is 
bound  to  proteins  &  other  macromolecules. 
 The  normal  magnesium  content  in  the  diet  is  about  6-15 mmol / 
day20. Absorption of magnesium  takes  place  mainly  in  the  jejunum  &  
ileum which  is  30-40 %  of  the  total  dietary  magnesium. The  factor  which  
affects intestinal  magnesium  absorptive  efficiency  is  1,25 (OH)2D. Urinary 
magnesium  excretion  is  4 mmol/d  or  100mg/day and almost  same as nett 
intestinal  absorption. 
 About 20% of magnesium that is filtered gets  absorbed in the PCT or 
proximal  convoluted tubule and remaining 60% is reabsorbed in  ascending 
thick limb of loop of Henle and 5-10% in DCT  or  Distal convoluted Tubule. 
 Reabsorption of magnesium in the thick ascending limb is enhanced by 
parathormone  but inhibited by hypercalcemia or hypermagnesemia which also 
activates the CaSR  receptor   in this nephron segment20. 
HYPOMAGNESEMIA: 
 Hypomagnesaemia is often an under diagnosed electrolyte abnormality 
in day to day practice and its importance cannot be undervalued37.   
 There are several causes  of hypomagnesaemia in day to day  clinical 
practice  and  these include intractable vomiting, diarrhea, malabsorption 
syndrome, intestinal drainage, decreased renal tubular magnesium 
reabsorption,  and movement of the nutrient from  the ECF  to the cell, bone 
and  third space. 
 Hypomagnesaemia is found in acquired kidney diseases like tubulo 
interstitial disease, acute tubular necrosis, obstructive uropathy and  in kidney  
transplantation. 
 Chronic alcoholism has been found to be associated with dietary 
magnesium deficiency and  in turn leading on to hypomagnesaemia37. 
 Poorly controlled Diabetes mellitus is associated with hypomagnesemia 
which is due to decreased tubular magnesium reabsorption and persistent 
glycosuria with osmotic diuresis35. 
 Recovery from Diabetic ketoacidosis causes hypomagnesemia. Other 
conditions are starvation & respiratory acidosis. The mechanism in these 
conditions is due to rapid shifts of magnesium from extracellular  fluid into the 
intracellular fluid. 
 Magnesium depletion in the  human  system has been found to be 
associated with sepsis and systemic inflammatory response syndrome. 
 Hypomagnesemia is also associated with burns  which are extensive, 
acute pancreatitis,excessive sweating and also in pregnancy & lactation. 
 Hypomagnesemia can also be caused by drugs like pentamidine, 
amphotericin B, cyclosporine, foscarnet, diuretics, cisplatin and cetuximab- 
which is an EGF receptor inhibitory antibody20. 
Hypomagnesaemia is associated with certain rare genetic disorders like 
primary infantile hypomagnesemia, hypomagnesemia with secondary 
hypocalcemia caused by gene mutations in TRPM 6 &TRPM 7 genes26. 
 Other genetic magnesium wasting syndromes  include Gitelman 
syndrome.  Gitelman syndrome is caused by inactivating  mutations of genes 
encoding the DCT NaCL co-transporter.  
Other syndromes are Bartter’s syndrome, autosomal recessive renal 
hypomagnesemia with hypercalciuria and autosomal dominant renal 
hypomagnesemia with hypocalciuria24,25. 
 In Bartter’s syndrome, mutation of genes encoding proteins required for 
cTAL Na-K-2 Cl transport is seen. There is mutation of the genes encoding 
paracellin-1  in  autosomal  recessive renal hypomagnesemia with 
hypercalciuria and mutation of gene encoding DCT- Na+ K+ ATPase gamma  
subunit in autosomal dominant renal hypomagnesemia with hypocalciuria. 
 
 
 
 
 
 
 
HYPOMAGNESEMIA IN INTENSIVE CARE UNIT PATIENTS 
 Magnesium deficiency in the intensive care unit patients has three main 
causes16,18,19. 
They are 
1. Increased renal losses 
2. Reduced intestinal absorption.  
3. Compartmental redistribution 
1.  Due to loss  through  the kidneys are 
Specific tubular defect: 
 ATN  or Acute Tubular Necrosis 
 Interstitial nephritis 
 Post obstructive diuresis 
 After renal transplantation 
Drug induced 
 Amphotericin B 
 Foscarnet 
 Cyclosporin- A 
 gentamycin 
 Pentamidine 
 cisplatin 
 CSF  or  Colony stimulating factor  
The  endocrine causes are  diabetic  ketoacidosis,  alcoholic ketoacidosis 
hyperaldosteronism, hyperthyroidism,hyperparathyroidism  & SIADH. 
2. Due to the distribution of magnesium are  
 Acute respiratory alkalosis 
 Hungry bone syndrome 
 Administration of epinephrine 
 Acute pancreatitis 
 Blood transfusion  
 Also, extensive burns 
 increased sweating 
 cardiopulmonary bypass surgery  
     alcohol dependence syndrome  
1. Gastrointestinal causes include 
 Nutritional disturbances 
 Refeeding syndrome 
 TPN  
Impaired intestinal  absorption: 
 Malabsorptive  states 
 Short bowel syndrome 
     Chronic diarrhea 
     Pancreatitis 
 Prolonged nasogastric suction 
     Biliary, intestinal fistula. 
 
  
 
 
 
 
  
CLINICAL FEATURES OF HYPOMAGNESEMIA 
 Hypomagnesemia is associated with a wide variety of clinical 
manifestations, especially in the central nervous system and cardiovascular 
system.  
 The features include convulsions, generalised muscle weakness, ataxia, 
nystagmus, vertigo, apathy, tremors & tetany. 
 It can also cause certain psychiatric manifestations like depression, 
psychosis, irritability and even it may lead on to delirium. 
 Severity of symptoms may not correlate with the serum magnesium 
levels. 
 In the cardiovascular system, hypomagnesemia causes life threatening 
arrhythmias like ventricular arrhythmias and also sinus tachycardia and other 
supraventricular  tachycardias 20. 
 ECG findings include prolonged PR or QT intervals, flat T waves or 
inverted T waves and straight  ST segment. 
 In the presence of other electrolyte  abnormalities like hypocalcemia and 
hypokalemia, magnesium should be administered, for favorable clinical 
outcome. 
 
TREATMENT OF HYPOMAGNESEMIA 
 Hypomagnesemia  may be classified as mild asymptomatic type and 
severe type. 
 Oral magnesium supplements like magnesium chloride, magnesium 
hydroxide, and magnesium oxide is usually given to treat mild asymptomatic 
hypomagnesaemia in divided dosages and upto  20-30 mmol/ day (40-60 meq/ 
day) 
 Severe hypomagnesemia is treated parenterally with intravenous 
magnesium chloride as an intravenous administration of 50 mmol/ day which 
is to be continued, if renal function is normal. If GFR is reduced, infusion is 
lowered by 50-75%. There should be close monitoring of serum magnesium at 
intervals of 12 hours to one day   during treatment and it is continued for 
several days. Calcium, potassium & phosphate supplementation is important in 
patients with hypomagnesemia. Vitamin D deficiency should be treated with 
oral or parenteral  vitamin D.  
 Administration of intravenous magnesium alone may worsen 
hypophosphatemia leading on to neuromuscular symptoms or rhabdomyolysis 
due to rapid PTH secretion.  
 
 
HYPERMAGNESEMIA 
Hypermagnesemia is rarer than hypomagnesemia and is   seen mostly in 
the setting of kidney disease. Mild hypermagnesemia is seen in some patients 
with hypothermia, hypoadrenalism ,hypothyroidism,and with increased 
reabsorption in cTAL due to Ca SR  mutations in familial hypocalciuric 
hypercalcemia. Massive soft tissue injury can push large amounts of 
magnesium into the extracellular fluid in patients with shock, sepsis, burns or 
cardiac arrest. 
Causes of hypermagnesemia 
1.Increased mobilization from tissues 
a) burns 
b) cardiac arrest 
c) trauma 
d) shock 
e) sepsis. 
2.Increased magnesium intake 
a) parenteral magnesium 
b) urologic irrigants,cathartics 
3.Decreased excretion  
a) familial hypocalciuric hypercalcemia 
b) renal failure 
Other causes are : 
a) hypothyroidism 
b) hypothermia 
c) hypoadrenalism  
CLINICAL FEATURES 
An early sign of hypermagnesemia is hypotension that does not respond 
to vasopressors or volume expansion. Vasodilation and neuromuscular 
blockade are quite prominent in hypermagnesemia ie. Serum magnesium >2 
mmol/L(>4 meq/L). 
At serum  magnesium > 4 mmol/L  respiratory failure, paralysis, coma 
with  hypoactive tendon reflexes,intestinal ileus, facial flushing, mydriasis 
bradycardia   are seen. 
ECG findings are increased duration of PR interval, QRS, QT  interval, 
heart blocks and at magnesium concentrations>10 mmol/L, asystole  is seen. 
TREATMENT  OF  HYPERMAGNESEMIA 
The  treatment  depends  on the  clinical scenario.  
In the  setting  of  renal  injury  renal  replacement  therapy  in  the  form 
of  hemodialysis  may be indicated  .Intravenous  volume  replacement  is  
required  in  other  situations. Enemas  or  cathartics  which  do  not  contain  
any  magnesium  may  be  needed  to  remove  ingested  magnesium  from  the  
alimentary  tract. Intravenous  calcium  in the  dose range   100-200  mg  in a 
time period ranging  one to two  hours  leads on to the  clinical  recovery of 
many  patients. Aggresive  rehydration  may  be required  in some  cases. 
 
 
 
 
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS) 
 Systemic inflammatory response syndrome is an inflammatory condition 
which affects various systems  of the body. Fever or hypothermia, leucocytosis 
and  leucopenia, tachycardia  and tachypnea are the important clinical  signs of 
the systemic response that is termed the systemic inflammatory response 
syndrome20. 
 SIRS can be due to infectious or non infectious etiology20. An individual 
with SIRS is considered to be in a state of sepsis if infection is suspected or 
proven. 
 
 When sepsis is seen to be associated with impairment of function of  
organs  away  from  the origin of infection, the patient is said to have  severe 
sepsis. 
 If severe sepsis is associated with hypotension which could not be 
treated by intravenous fluid therapy then septic shock  is  the diagnosis . 
Definitions: 
1. SIRS : Defined by the presence of two or more of the following conditions. 
1.  Fever (oral temperature > 380c ) or hypothermia (<360c) 
2.  Tachypnea (> 24 breaths / Min) 
3.  Tachycardia (Heart rate >90 beats / min) 
4.  Leucocytosis (>12,000/ mm3) 
 leucopenia (<4000/mm3) 
     or >10% bands; may have a non infectious etiology. 
For confirming the diagnosis of SIRS two or more of the criteria 
mentioned above should be met. The above mentioned criteria was proposed in 
1992 in the American College of Chest Physicians / Society  of   Critical Care 
Medicine Consensus Conference20. 
 
Sepsis: 
 SIRS which has a proven or suspicious microbial cause. 
Severe sepsis: 
Sepsis with one or more signs of organ dysfunction.  
    for example 
1. Cardiovascular: 
 Systolic arterial blood pressure less than 90 mm Hg or mean 
arterial pressure less than 70 mm of Hg that responds to administration 
of intravenous fluids. 
2. Renal: 
 Urine output <0.5 ml/ kg per hour for 1 hour despite adequate 
fluid resuscitation. 
3. Respiratory: 
 Pa 02/ FI 02   less than or equal to 250 or in case of  lung  being the 
only affected  organ less than or equal to 200. 
Hematologic: 
 Thrombocytopenia which is count less than 80000 / µL or 50% 
decrease in platelet count from highest value recorded over last 3 days. 
4. Unexplained metabolic  acidosis: A pH less than or equal to 7.30 or 
base deficit greater than or equal to 5.0 meq/l and plasma  lactate >1.5 
times upper limit of normal. 
5. Adequate fluid resuscitation: 
 Pulmonary Artery Wedge Pressure greater than or equal to 12 mm 
Hg or central venous pressure  greater than or equal to  8 mm Hg. 
Septic Shock: 
 Sepsis with hypotension (Arterial systolic blood pressure < 90 mm Hg  
or 40 mm Hg less than patient’s normal blood pressure)  for atleast 1 hour 
despite resuscitation or  need for vasopressors  to maintain systolic blood  
pressure  > 90 mm Hg or mean arterial pressure > 70 mm Hg. 
 Refractory septic shock: 
 Septic shock that goes on for more than one hour and which does not  
improve with administration of vasopressor agents and intravenous fluids.  
 
Multiple Organ Dysfunction Syndrome (MODS) 
When there is impairment of function of more than one organ and it is 
required to intervene promptly for maintenance of homeostasis. 
SIRS may have non- infections causes like extensive soft tissue injury,  
massive burns, pancreatitis and haemorrhage. 
 
 
Other etiologies are: 
1.  Post operative states 
2.  Anaphylaxis 
3.  Drug overdose 
4.  Cardiac tamponade 
5.  Pulmonary embolism 
6. Adrenal insufficiency 
  
Pathophysiology of  SIRS and sepsis: 
 Sepsis is systemic inflammatory response syndrome  with suspicious or 
proven infectious etiology. 
 
 
 
 
  
  
  
 Sepsis is usually triggered by infectious agent like fungi or  bacteria   
which does not lead on to any disease affecting  many of the systems in a  
person with  intact  immunity. 
 The  body will respond with a vigorous inflammatory reaction that  
results in severe sepsis, yet fails to kill the invaders. 
INFECTION                    SIRS S 
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 SIRS is a consequence of the combined effect of the inflammatory  
mediators  involved  in acute  phase reaction response in the body. 
Inflammatory	response	
 
Inflammation  is  a  part  of  the  biologic  response  of  the  vascular 
tissue to pathogens , harmful irritants and damaged cells . 
The  phenomenon called  inflammation involves vasodilatation which 
leads  on  to  an increase in the  blood  flow  to  the  involved  organ, increased 
permeability of capillary wall and  transmigration of inflammatory  cells into 
the target site. There is triggering of protective immune  mechanism and the 
cells, plasma enzymes, and clotting factors and complement entities. This 
activation is equal to the extent of the cellular  injury. 
The local signs in  inflammatory  response  like rubor, tumor, calor, 
dolor and functio laesa are classically  seen. 
Acute	phase	response	
The acute phase response  is the  inbuilt unique adaptive response to  
tissue damage. They  are a  set  of responses brought  out by humoral 
mediators and  certain other factors, especially  cytokines  which  favour   
inflammation  like  interleukin1, interleukin 2, interleukin 6 and  tumor  
necrosis factor alpha . 
The acute phase  reactant  proteins comprise a set of proteins which 
increase or decrease in response to inflammation. They are broadly divided as 
positive acute phase reactant proteins and negative acute phase reactants. The  
positive  acute  phase  reactant  proteins  are ferritin, C-reactive protein, 
ceruloplasmin, haptoglobulin, serum amyloid A and complement factors. The 
negative  acute phase reactants are albumin, transthyretin, transferrin, retinol 
binding protein. 
The acute phase response is vital  in maintaining  homeostasis in water 
temperature, and   ion  balance.and  removal  of  irreversibly damaged tissue,  
and regenerative and reparative processes . 
    Systemic  inflammatory  response  syndrome is a complicated  response  
as compared  to acute  phase response .Systemic  inflammatory response 
syndrome  can lead  on to much  complicated  disturbances in the  normal  
homeostatic mechanism leading  on to potential  damaging  effect  on the  
system. 
SIRS, independent of the cause can  have  the  same  pathogenetic  
mechanisms and  there can be small  variations  in  the  effects  which  are 
described. Inflammatory  response  is  the response  of the  body  to  insults  
which  are  not  specific and  are  due  to  infectious  diseases, chemicals  or  
external  traumatic  insults. The inflammatory  process is  a complicated  
response which  invoves cellular and humoral responses and  the  complement  
and  cytokine  related  systems. 
The association between systemic  inflammatory  response  syndrome 
and  these complicated  interactions are : 
 1.  After  an inciting  stimulus , localised  cytokines are generated with the 
aim of producing  inflammation and then  helps  in repair  of wounds  and  
activation of  the  system invoving  the reticuloendothelial cells . 
2. The cytokines  get  access to  the  circulatory  system and  leads  on to  a 
better  effect. This leads to stimulation  of  factors  involved  in  activation of 
macrophages   and  platelets and certain growth factors. The  acute  phase 
reaction is well  adjusted  by   decreased  proinflammatory mediators and    
due  to  the production  and  action of  certain  factors  which  are  antagonistic.  
3.  In  case there is no achievement  of  homeostasis there  is  a response  
involving  the system and  the cytokines  which  are destructive. This  leads on 
to stimulation of several  systems  and also  the  reticuloendothelial system and 
consequent  disturbances  in the  circulatory  system and  there is  impairment  
of  function  of  the  organs. 
The inflammatory  system is  activated  by  stimuli  like  infectious  
diseases, inflammatory  stimuli  and  traumatic  insults. Endotoxin or  exotoxin  
initiates  the  inflammatory  system when  systemic inflammatory  response is  
due  to  infectious  diseases. A  wide  spectrum of cytokines  are generated  by  
the endothelium, monocytes and macrophages. Tumor  necrosis  factor  alpha 
and  interleukin 1 released leads  on to  the  splitting  of  nuclear  factor kB 
inhibitor. After  the  absence  of  inhibitor,nuclear factor  Kb leads on to 
release  of  mRNA ,later  on leading  to  the generation of  cytokines  which  
are  favouring  inflammation. Interferon  gamm ,interleukin 6 and 8  are 
proinflammatory cytokines released  if  viruses  are responsible  for  
inflammation .Interferon gamma is  generated  from the  tissues  devastated  by  
the viral insult. 
   Tumor necrosis factor alpha & interleukin 1 leads  on to  hyperthermia 
and  generation of certain stress responses like  for  example  stimulation of  
vasopressin  and the  renin-AT system. Interleukin 1  and  tumor necrosis  
factor  alpha can  lead  on to pulmonary pathology and  hemodynamic  failure 
if  they  are acting at the same  time and  not when acting  singly.  
Infectious  diseases lead  on to hyperthermia due to  release of tumor 
necrosis factor alpha more than in the case of  traumatic  injury. C-reactive 
protein is  generated  due  to  the  release  of  cytokines  like  interleukin 6. 
There is stimulation of the clotting system, complement system and production 
of  platelet activating  factor, leukotrienes and complement  system. 
Several inflammatory peptides lead on to  the  production of certain 
cytokines  and lead  on to  dilatation of blood  vessels  and  aggravated  blood  
vessel permeability .Good  examples  are  complements 3a and  5a.  
 Certain  factors  lead  on to  endothelial  injury  and  several  organ systems  
are  badly  affected. Leukotriene B4 is  responsible for this  effect  as  also 
prostaglandin compounds. 
For  comprehending the  future  consequences  of  SIRS  the  association 
between  clotting  response and  inflammatory syndrome  is vital . Tissue  
factor  leads  on to  thrombin genesis and  thus  initiation of clotting  pathway  
and  thus  inflammatory response  is  aggravated. Cytokines like interleukin 1 
and tumor necrosis factor alpha act on endothelium  and  lead  on to tissue  
factor production. Thus  the process  of  inflammation is  activated  in part  
also  by  the  clotting  cascade. Due to  the production of PAI-1,splitting  of 
fibrin is inhibited by  interleukin 1 and tumour  necrosis factor  alpha. Splitting 
of fibrin is impaired by interleukin 1 and tumor necrosis factor alpha by 
producing plasminogen activator inhibitor-1.  
The complement cascade is vital  in the clotting  mechanism of body. 
Uncontrolled  clotting  factor  activation can lead  on to  vascular  obstruction 
with  blood clots  later  leading  on to multi system failure.This  is  because 
anti clotting mechanisms  of  body  like  APC  is  affected. 
There  is  activation of  clotting  system  due  to  the process of sepsis 
and  it is more critical  than due  to  other  insults. There is disruption of  
homoeostasis leading  to  dominant  clotting  pathway  activation. 
Symptomatology of  SIRS 
Hyperthermia 
The  temperature  controlling  centre  in the hypothalamus is acted  upon 
by the cytokines  and the thermogenic factors due to sepsis  which change the 
fixed temperature set point  to a much  higher  one .The factors  which 
generate more heat are activated  and there  is a decrease in the  loss of heat 
from  our body. This  regulation of set point  goes  on till  the  body responds  
with its inbuilt  immunological mechanism and  also due to the effect of 
therapy with  medications. 
Tachycardia 
In sepsis  the metabolic demand  of  the target tissues  is  increased  and  
the demand  for oxygen  to the  organ systems is increased .Increased heart rate 
is  one mechanism to  increase the oxygen supply to the vital organs. Also  
there will be  hypotension due to the action of cytokines which  inhibits the 
firing activity of baroeceptors therefore natural high activity of sympathetic 
centre is prominent. So the  heart  rate  is increased by this mechanism also in 
sepsis. 
There is increased contractility of the myocardium due to this effect. 
Decreased  blood pressure 
There is a drop in blood pressure because of the dilation of small blood 
vessels  in the periphery which can be attributed to the action of the cytokines 
and certain factors which favour inflammation  leading on to dilatation of  the 
blood  vessels. Also  there is an inhibitory  effect of these mediators  on the 
cardiovascular system. 
Tachypnea  
  The reason for increase in respiratory rate  in SIRS is complicated .In 
SIRS or sepsis there is aggravated  demand of oxygen to  the  tissues and vital 
organs and hence there is  a need to increase the ventilatory response  so  as to 
absorb more oxygen into the circulation. Breathing which is shallow and fast is 
brought out as a compensatory temperature regulating response. Hypocapnia is 
seen in hyperventilatory response  and respiratory alkalosis occurs  in the 
system as a result  of hypocapnia. 
Effect  on leucocytes 
As a result of release of cytokines favouring inflammation the 
leucocytes in the marrow get activated and hence proliferate and mature which 
leads on to adequate immunological protection and young immature 
leucocytes  are produced and sent into  the circulation from the marrow for  
protective function.  
 
Leucopenia 
There is a decrease in number of leucocytes as a result of  certain phases  
of inflammation like  leucocyte rolling, leucocyte adhesion and transmigration. 
The  leucocytes are not promptly replaced from the bone marrow  and leads on 
to leucopenia in case of sepsis .The normal leucocyte count  might not be 
replenished in such a stress situation in the bone marrow of human body. 
The progression and consequences of SIRS depends on the effect of 
response of inflammatory and anti inflammatory  mechanisms  in body at  
tissue  level and multisystem level. The body has got a counter inflammatory  
response process  against the systemic inflammatory syndrome which is 
supposed to oppose and correct the effects of systemic inflammatory response 
on body as a whole. This  mechanism is based on the fact that body stimulates 
it to oppose SIRS and both of them operate at the same time. The balance 
between the SIRS and the anti inflammatory syndrome is a proof  of the 
balance between adequate inflammation and the  level of suppression of  
body’s immunity. 
Interleukins 4 and 10  decrease the release of interleukins 1,6 and 8 and 
tumor necrosis factor  alpha.The antagonists to Tumor  necrosis factor alpha 
and interleukin 1 are generated which act on these cytokines and lead to 
dysfunction and receptor blockade.The  ultimate result of the interaction of 
proinflammatory and anti inflammatory  responses  will decide the prognosis 
of a seriously ill individual with SIRS.  
The associated disease conditions will affect the response of an 
individual to such stress or insults. Both inflammatory and anti inflammatory 
responses occur simultaneously and there should be a homeostasis maintained 
even after the inflammatory and anti inflammatory response by the system. If 
the balance is destroyed there is a possibility of severe SIRS leading to tissue 
destruction and end organ damage and mortality .Another possibility is that 
there can be suppressed immunity leading on to other opportunistic insults and 
further leading on to death of the individual. 
 End organ damage in SIRS 
The causes  for end organ damage in sepsis are  
1. dilatation of blood vessels  
2. increase in vascular permeability 
3. destruction of endothelium and production of  certain mediators 
and microthrombus in the small blood vessels leading to DIC. 
4. free radical release by the polymorphs.  
5. generation of certain proteolytic enzymes by polymorphs.  
6. nitric oxide  synthesis by the enzyme nitric oxide synthetase.   
 
Pulmonary system 
Respiratory failure is frequently encountered in systemic inflammatory 
response syndrome and leads on to the clinical manifestations like increased 
respiratory rate, hypoxia and alkalosis. It further deteriorates the condition of 
the patient leading to acute lung injury and ARDS. The pathogenetic 
mechanism is that there is injury to endothelium in the lung capillary vessels 
and this leads on to exudation of inflammatory cell rich fluid into the alveoli 
and interstitium. The cytokines increase the vascular permeability .There is 
destruction of  pneumocytes  which are supposed to produce surfactant and 
and also the integrity of the alveoli and basement membrane is also lost. This 
later on leads to atelectiasis in the lungs. 
Cardiovascular system 
   Cytokines act on the cardiovascular system  to cause the cardiac 
complications of SIRS.Nitric oxide is produced by nitric oxide synthetase and 
it is the cause for peripheral  vasodilation which occurs in the system and there 
is in turn drop in the blood pressure. NO is produced from L-Arginine in 
endothelium of blood vessels by the enzyme. The drop in blood pressure  may 
not improve  with aggressive volume replacement, inotropic agents and 
vasoconstrictor agents. There is increased cardiac output  due to hypotension. 
There is increased heart rate and stroke volume as the afterload decreases. 
There is depression of myocardial contractility due to the action of cytokines 
in SIRS. Myocardial depression is due to the action of nitric oxide .In what 
manner the myocardium responds to beta adrenergic drugs  is also dependent 
on nitric oxide. 
Kidneys 
Acute kidney injury in SIRS is due to multitude of factors20.The normal 
autoregulatory function of renal afferent and efferent arterioles is affected and 
so blood supply to the kidneys and the GFR is decreased significantly.There is 
disturbance of the autoregulatory function in sepsis and SIRS.The decreased 
hemoperfusion is due to the effect of cytokines and volume loss which is not 
absolute. 
The blood pressure of the patient need not  predict the blood flow to the 
kidneys. Certain factors which constrict the blood vessels are produced as a 
result of inflammatory factors and the renin- AT-  aldosterone system. Some of 
the factors have a renoprotective effect and others have an adverse effect. 
Like in the case of other organs the kidneys are susceptible to white 
blood cell mediated cell injury and accumulation of polymorphs and 
generation of certain free radical species and proteolytic enzymes. 
Gastrointestinal tract 
In the gastrointestinal tract, there is decreased blood supply to  the 
organs and the normal protective barrier is lost due to this decreased 
hemoperfusion to the gut. The real danger is when the bacteria seen inside the 
lumen of gut gets transported to the systemic circulation .The endotoxins also 
transmigrate in a similar manner. 
Then there is a real risk of septicaemia and further aggravation of the 
condition of the patient. There may also be hemodynamic decompensation 
worsening as a result. 
 
Metabolic dysfunction 
Hypoxemia and elevated lactic acid levels are a consequence of the 
changes that occur in the hemodynamics due to the effects of inflammatory  
state leading on organ hypoperfusion and redirection of the blood. The novel 
approach to  treatment of such  conditions  is to increase oxygen supply to the 
vital organs and avoid cell death. Nitric oxide mediates this effect at the level 
of mitochondria and thus electron transport process is affected at receptor for 
cytochrome oxidase. Then there is increased production of free radicals and 
decreased oxygen delivery to the tissues.  
Coagulopathy 
Coagulopathy is seen in SIRS due to the action of cytokines on clotting 
mechanism of the body20.DIC or disseminated intravascular coagulation leads 
on to  both thrombosis and hemorrhage and leads on to end organ failure. The 
extrinsic pathway mediated by tissue factor is involved in the coagulopathy  
seen in SIRS.   
The tissue factor is responsible for the activation   and  is  the cofactor 
for  factor VIIa  and activation of factors IX and X of the extrinsic pathway. 
Tissue  factor is produced by endothelium and macrophages as a response to 
interleukins 6 and 8, complements and endotoxin. The clotting  system is 
activated and anti clotting system is inhibited to certain extent. An important 
factor in the anti clotting mechanism is antithrombin III. Another vital factor  
in anti clotting  system is the thrombomodulin which is produced by 
endothelium and causes lysis of fibrin .Thrombin- thrombomodulin compound 
leads on to the activation of protein C with protein S and factors 5 and 8 are 
inactivated. In patients with SIRS there is decreased thrombomodulin under 
the effect of certain inflammatory  factors and also protein S levels are 
decreased.   
MAGNESIUM  AND  SIRS 
Magnesium levels in Systemic Inflammatory Response Syndrome patients 
in the intensive care unit   has been the  important part of this study. 
Several studies have been done to demonstrate the prevalence of 
abnormalities in serum magnesium levels in seriously ill patients upon 
admission to medical Intensive Care Unit36. Among the critically ill patients 
malnutrition is a widely acknowledged issue that may aggravate underlying 
illnesses and increase the risk of complications, so it is essential to have a 
nutritional assessment upon admission to the intensive care unit to identify the 
patients at risk and to guide nutritional supplementation during the stay in 
ICU36,39 . 
Magnesium deficiency is an often found electrolyte abnormality found in 
seriously ill patients 37. 
The prevalence of magnesium deficiency ranges from  11 to 61%  as 
reported in certain international studies and it has various effects on morbidity 
& mortality6 . 
Magnesium deficiency is also associated with worse clinical outcome 
among patients under intensive care.  
There is dysfunction of heart and blood vessels as a result of magnesium 
depletion and SIRS in the intensive care  unit patients40. Hypomagnesemia  is  
also associated with other chronic diseases states. Association with diabetes 
mellitus has been reported which is as a result of loss of this mineral through 
the kidney route along with glycosuria.13 It has been found that magnesium 
depletion and resistance to the action of insulin on its receptors is  related35 . 
Administration of magnesium may lead to lesser requirement of insulin34,35. 
An important factor responsible for magnesium deficiency is  chronic alcohol 
abuse. 30% of the hospital admissions with alcohol intoxication have been 
found to have hypomagnesemia and 85% in cases with delirium tremens10. 
Magnesium deficiency in alcoholics may be as a result of multiple causes like 
malnutrition, pancreatitis, alcohol withdrawal syndrome and abnormality in 
renal tubules due to alcoholism and further leading on to loss of magnesium 
through the kidneys10. 
Hypomagnesemia was found to be associated with 33% of patients with 
chronic liver disease and alcoholism by Soliman et al5.Magnesium  deficiency 
is associated with sepsis & SIRS in intensive care unit37.  
Immunoregulatory  effects of hypomagnesemia and magnesium has been 
increasingly reported 9. There is data available which shows that reduction in 
magnesium in the cells and in the circulation can have certain vital clinically 
relevant effects in sepsis and shock states31,32.  
 Hypomagnesaemia promotes inflammatory tissue injury  by increased  
production of free radical species and synthesis of cytokines. Circulating  free  
magnesium  ions  are supposed to antagonise the action of calcium and affect 
the entry of calcium into the cells in states of sepsis  as proposed  by  Altura et 
al41. Hypomanesemia leads on to calcium to move from the sarcoplasmic 
reticulum of muscle cells in experimental animals at a magnesium level of 0.3  
to 3 millimol. It was found that low ionized magnesium leads to  increased  
voltage  gated calcium current27. It  was found  that intracellular calcium 
increases when magnesium concentration in tissues decrease in an endotoxin 
shock experiment on mice. Magnesium  deficiency  leads  on  to  abnormal  
cellular calcium entry  during SIRS and which will lead on to aggravated free 
cytoplasmic calcium and in the mitochondria which leads on to death of the 
cells.   
Due to the fact that much amount of magnesium in the cells is attached 
to adenosine triphosphate, in the setting of SIRS decreased  production of ATP 
will cause  releasing of magnesium ions in the cells32,33. Later on levels  of 
ionised magnesium increases and magnesium is removed from the cell.   
It leads on to  
  (1)  decreased sodium potassium ATPase function . 
  (2) decreased  potassium ion channels. 
  (3)defective calcium channels in the cell membrane and sarcolemma..  
The above said effects can explain the aggravated danger of endotoxin 
increase which is encountered in experimental animals in magnesium 
deficiency and also protection offered by magnesium administration . 
Magnesium controls vital immune function like stimulation of the 
macrophages, destruction of bacteria and polymorph cell adhesion,  increased 
lymphocytes and monocyte bound by endotoxin.. 
  There is alteration in binding of DNA to transcription elements which 
are supposed to inhibit the gene stimulation for the proinflammatory cytokines. 
Also it was researched and found by Mak et al that there is release of NO or 
nitric oxide in experiments on mice .The production of  NO was due to the 
activation of synthetase enzyme  and also the enzyme which is sensitive to 
calcium. 
  The cellular  toxic consequences  of nitric oxide  are  due to  its 
combining with superoxides  to produce per-oxynitrates.  
The  process of oxygen assimilation in the cell and mitochondrial  
system is affected due to the inhibition of haeme containing enzymeswhich 
further aggravates cell death and tissue injury  .The vast amount of information 
that is coming out has shed light on the fact that prompt identification  of 
hypomagnesemia  and correction with prompt magnesium administration may 
in the long run lead to favourable results.This may be due to the fact that 
magnesium has vital role to play in the normal metabolic process of human 
body. A lot of research  is  needed towards the aspect mentioned in future 
times. 
 
 
 
 
 
 
 
 
MATERIALS  AND METHODS 
The study was done with the aim of estimating the serum magnesium 
levels in Systemic inflammatory response syndrome patients in the Intensive 
Care Unit and assessing the prognostic value of serum magnesium in these  
patients. 
DESIGN OF STUDY 
Observational analytical study. 
STUDY POPULATION: 
The  study  was  conducted  at  the  medical intensive  care  unit  of 
Government  Rajaji Hospital, Madurai on 50 patients after getting institutional 
ethical committee approval. Informed written consent was obtained from each 
patient before being included in the study. 
INCLUSION CRITERIA 
The patients admitted to the Intensive Medical Care Unit of Government 
Rajaji Hospital, Madurai ,who satisfy the diagnostic clinical criteria for 
Systemic Inflammatory Response Syndrome   during the period from April 
2012 to October 2012. 
 
EXCLUSION  CRITERIA     
1.   Patients with chronic kidney disease. 
2.  Patients on diuretic therapy. 
3.  Patients with history of alcohol abuse. 
4.  Patients receiving magnesium supplements. or magnesium containing      
antacids. 
5.  Chronic diarrhea or malabsorptive states. 
6,   H/o   recent myocardial infarction less than 6 months. 
DATA  COLLECTION 
A total of 50 ICU patients were included in the study after obtaining 
informed written consent .Detailed history and history of other underlying 
disease conditions including hypertension ,diabetes mellitus, ischemic heart 
diseases, chronic kidney disease,chronic diarrhea was taken. History of chronic 
drug intake, and other systemic illness were obtained. History of fever and 
breathlessness was noted. Temperature and other vital signs were recorded. 
Detailed  clinical  examination was  done for  each  patient. The 
diagnosis of systemic inflammatory response syndrome was confirmed for 
each patient before he/she was included in the study. 
LABORATORY INVESTIGATIONS     
Complete blood count and differential cell count 
serum creatinine  
S.bilirubin, 
Serum magnesium 
serum sodium  
Serum potassium           
Calmagite dye method for quantitative estimation of serum magnesium  
Test principle: 
Under alkaline conditions magnesium ions react with calmagite dye to 
form  a reddish  complex which is measured spectrophotometrically at 530  
nanometer. Intensity of the colour produced is directly related  to the serum 
magnesium concentration  .To eliminate the interference of calcium during 
estimation, EDTA is included in the reagent. Cyanide prevents interference by 
heavy metals and there is induction of surfactant system to prevent 
interference by proteins.  
Magnesium + Calmagite-- ->Red coloured complex 
 
 
Test procedure: 
Three test tubes labeled Blank, Standard and Test are prepared as in table. 
In test tubes              blank standard test 
Calmagite reagent    1.0 ml 1.0 ml 1.0 ml 
Standard reagent       - 10 ml  
Patient’s sample       - - 10 ml 
Distilled water          10 ml - - 
 
Three test tubes are incubated at room temperature (22-28ºC). The 
absorbance of Test (AT), Standard (AS) and Blank (AB) are read at 530nm in 
spectrophotometer. Magnesium concentration is calculated by the following 
formula. 
Magnesium concentration (mEq/L) = (AT-AB / AS-AB) x 2 
Serum magnesium concentration is expressed in mg/dl by linearity of 1 
mEq/L = 1.2 mg/dl. 
The patients are the divided into 3 groups based on the levels of serum 
magnesium as : 
Normal  : 1.3 to 2.5 meq/L. 
Hypomagnesemia :  less than 1.3 meq/L. 
Hypermagnesemia : >2.5 meq/L. 
The patients were followed  up in the study regarding mortality rate and 
other aspects like duration of ICU stay ,necessity of mechanical ventilation and 
period under ventilator support. 
STATISTICAL TOOLS 
The data which was collected as regards the patients included in the 
study were recorded in a Master Chart. 
 Statistical analysis: 
Analysis was performed with SIGMA STAT 3.5 version statistical 
package. All continuous variables were presented as mean ±standard deviation 
if they were normally distributed. Differences in the normally distributed 
variables were assessed using the t-test and the ONE WAY ANOVA for 
dependent variable and chi square test. Comparisons between the two 
individual groups were performed using the unpaired t-test (parametric). All 
tests were two-sided and a probability value of p < 0.05 was considered 
statistically significant. 
 
 
 
 
                                          
                                   RESULTS 
 
TABLE – 1 
AGE DISTRIBUTION 
Age in years No.of cases Percentage 
<  20 3 6 
21 – 40 22 44 
41 – 60 16 32 
> 60 9 18 
Total 50 100 
   
 In the study, 50  patients were included and  22 patients  (44 %) were  in  
the  21-40  yrs  age  group. The  mean age of  the study  population was  42.92  
+  16.69 years. 
The median age  was  41 yrs.                                 
The lowest age was 14 years and highest  age  was  79 years. 
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TABLE – 2 
SEX DISTRIBUTION 
 
SEX No.of cases Percentage 
Male 35 70 
Female 15 30 
Total 50 100 
 
 
70 %  of  the patients  in the study  group were  male (35) and 30  % 
were  females.(15) 
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TABLE – 3 
SERUM MAGNESIUM IN SIRS 
 
Serum 
magnesium 
No.of cases Percentage 
< 1.3 33 66 
1.3 – 2.5 14 28 
> 2.5 3 6 
Total 50 100 
 
In the study , 66 % patients(33)  were in the hypomagnesemia  group  
and 28 % (14)patients  were  in the normomagnesemia  group .3  patients had  
hypermagnesemia. 
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TABLE  4 
MORTALITY RATE IN SIRS 
 
 
Magnesium 
Mortality 
Yes Percentage No Percentage 
< 1.3         (33) 27 81.8 6 18.2 
1.3 – 2.5   (14) 2 14.3 12 85.7 
> 2.5        (3) 0 0 3 100 
 
 
The   mortality  rate  in the  hypomagnesemia  group  was  81.8 %  
whereas  it  was 14.3 %  in  the  normomagnesemia group  Significant greater   
mortality  rate  was  observed  in  the  hypomagnesemia  group  when  
compared  to  the  normomagnesemia  group. 
(P   value =    0.037)    
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TABLE   5 
SERUM MAGNESIUM  AND DURATION OF ICU STAY  
OF SIRS PATIENTS 
 
Magnesium Mean duration 
< 1.3        (33) 5.424 
1.3 – 2.5   (14) 5.286 
> 2.5        (3) 5.333 
 
    
The  mean  duration  of  ICU stay for  patients  in  the hypomagnesemia 
group  was  5.424  days and  in  the  normomagnesemia  group  it  was 5.286 
days. The difference  was  not  found  to be  statistically  significant. (P value 
=  0.865). 
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TABLE – 6 
SERUM MAGNESIUM AND NEED   FOR MECHANICAL 
VENTILATION IN SIRS 
 
 
Magnesium 
Ventilation Needed 
No.of cases Percentage 
< 1.3         (33) 25 66 
1.3 – 2.5   (14) 1 7.1 
> 2.5        (3) 0 0 
 
 Among  33 patients with  hypomagnesemia  25  patients   required 
mechanical  ventilation  and  it was 66 %. Among 14 patients in   
normomagnesemia  group,   1 patient  required ventilatory support.   
The difference  is  statistically significant. (P   =    < 0.001) . 
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TABLE – 7 
SERUM MAGNESIUM AND DURATION OF  MECHANICAL 
VENTILATION IN  SIRS 
 
 
Magnesium 
Duration of Ventilation 
Mean 
< 1.3         (33) 3.45 days 
1.3 – 2.5   (14) 2 days 
> 2.5        (3) 0 
 
 
The mean  duration  of mechanical  ventilatory  support  for  the 
hypomagnesemia  group  was  3.45   days   and  in  the  normomagnesemia  
group  was    2 days. The  difference  is   found  to  be  statistically  significant.  
(P   value =    < 0.001 ) 
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TABLE – 8 
SERUM MAGNESIUM  AND  HYPONATREMIA 
 
 
Magnesium 
SERUM SODIUM LEVEL 
< 135 meq/l > 135meq/l 
< 1.3         (33) 15  (45.4%) 18 (54.6%) 
1.3 – 2.5   (14) 7  (50.0%) 7 (50.0%) 
> 2.5        (3) 2 (66.7%) 1 (33.3%) 
Total 24 26 
 
 
Serum   sodium  levels  were  measured   to  look  for  incidence  of  
hyponatremia  in the  study group. 45.4 %  of   the  hypomagnesemia  group   
had  hyponatremia  while  50  %  of   the normomagnesemia  group  had  
hyponatremia. The difference was  not  found to be  statistically  significant.  
(P value   =  0.591) 
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TABLE – 8 
HYPOKALEMIA AND SERUM MAGNESIUM 
 
 
Magnesium 
SERUM POTASSIUM LEVEL 
< 3.5meq/l > 3.5 meq/l 
< 1.3         (33) 13  (39.3%) 20 (60.7%) 
1.3 – 2.5   (14) 10  (71.4%) 4 (28.6%) 
> 2.5        (3) 3 (100%) 0 
Total 26 24 
 
 Serum  potassium  levels were measured  in the  study. 39.3 % of the  
patients  (13)  in the  hypomagnesemia  group had  hypokalemia  while  71.4  
%  of  the patients  in  the  normomagnesemia  group  had  hypokalemia . 
Three  patients  in the  hypermagnesemia  group  had  hypokalemia  in  the  
study. The difference  among the  hypomagnesemia  and normomagnesemia  
group  was  not statistically  significant. (P  value  =  0.387 ) 
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TABLE – 9 
SERUM MAGNESIUM  AND DIABETES MELLITUS 
 
 
Magnesium 
DIABETES 
Yes No 
< 1.3         (33) 12  (36.3%) 21 (63.7%) 
1.3 – 2.5   (14) 6  (42.8%) 8 (57.2%) 
> 2.5        (3) 1 (33.4%) 2 (66.6%) 
Total 19 31 
 
    
36.3  % of the  patients  in the  hypomagnesemia  group  had diabetes 
mellitus  while 42.8 % in the  normomagnesemia group were  diabetic. One 
patient in the  hypermagnesemia  group  was  diabetic. The  difference  among 
hypomagnesemia  and normomagnesemia group  was  not found  to  be 
statistically  significant. (P =  0.982) 
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36.30%
42.80%
63.70%
57.20%
66.60%
33.40%
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
< 1.3  (33) 1.3 – 2.5 (14) > 2.5  (3)
Yes No
 
 
 
 
  
 
 
 
 
 
TABLE – 10 
HYPERTENSION AND SERUM MAGNESIUM 
 
 
Magnesium 
HYPERTENSION 
Yes No 
< 1.3         (33) 11 (33.3%) 22 (66.7%) 
1.3 – 2.5   (14) 5 (35.7%) 9 (64.3%) 
> 2.5        (3) 0 3 (100%) 
Total 16 34 
 
   
33.3  %  of the  patients  in the hypomagnesemia  group  were 
hypertensive  and  35.7%  patients  in the normomagnesemia  group  were  
hypertensive. The  difference  was  found to  be not  significant.(P =  0.387) 
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TABLE  -11 
SERUM   BILIRUBIN IN SIRS 
 
Serum Bilirubin  
Lowest 0.8 
Highest 1.5 
Mean 1.042 
 
 
The  lowest  value  of serum bilirubin  recorded  was  0.8  mg/dl  and  
the highest  value  recorded  was 1.5 mg/dl  with  a  mean  serum  bilirubin  
value  of  1.042  mg/dl.  
 
 
 
 
 
 
 
 
 
TABLE -12 
SERUM  CREATININE IN SIRS 
Serum  Creatinine  
Lowest 0.7 
Highest 3 
Mean 1.2 
 
The  highest  serum  creatinine  recorded  was  3  mg/dl  and  the  lowest  
value  was  0.7  mg/dl  .The  mean  value  of  serum  creatinine  was  1.2  
mg/dl. 
                                        
 
 
 
 
 
 
TABLE  - 13 
TEMPERATURE 
 
Temperature(F) No.of cases Percentage 
< 100.4 2 4 
100.4 – 102.4 47 94 
> 102.4 1 2 
 
 The  mean temperature  value  was 101.35 degree F 94 %  of  the 
patients  (47)  were  in  the recorded temperature  range  of  100.4- 102.4  
degree F.  
                                
 
 
 
       
 
TABLE  - 14 
HEART  RATE 
Heart Rate No.of cases Percentage 
90 – 100 21 42 
101 – 110 21 42 
> 110 8 16 
 
 
The  mean  heart   rate  was 103.52 per  minute.  
42 % patients  had  heart  rate in  the  range  101-110  and 16  %  had  
heart  rate > 110  per  minute. 
 
 
 
 
 
   
 
 
TABLE  - 15 
RESPIRATORY  RATE 
 
Respiratory Rate No.of cases Percentage 
< 26 17 34 
27 – 30 23 46 
> 30 10 20 
 
Mean respiratory  rate  value  was 28.52/min. 
46 %  patients  were  in the  27-30   range  for  respiratory  rate  and 
34% patients  had  respiratory  rate  less than  26. 
 20  % patients  had  respiratory rate  greater  than  30 /min. 
 
 
 
 
 
 
 TABLE -16 
LEUCOCYTOSIS IN SIRS 
 
Leucocytosis No.of cases Percentage 
Yes 27 54 
No 23 46 
Total 50 100 
 
 
In  the  study  27  patients  had  leucocytosis  which  was  54  % . 
 
 
 
 
 
 
 
 
  
LEUCOCYTOSIS IN SIRS
54%
46%
Yes No
 
 
 
 
 
 
 
 
 
 
 
TABLE- 17 
LEUCOPENIA IN SIRS 
 
Leucopenia No.of cases Percentage 
Yes 7 14 
No 43 86 
Total 50 100 
 
In  the study  7 cases  had  leucopenia  on  blood  investigation  which  
came  to  14  %.   
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DISCUSSION 
 
Magnesium  is  a  vital  electrolyte  in  the  normal  metabolism  of  the 
human  body. The  deficiency  of magnesium  can  lead  on  to  disastrous  
consequences  if  not  detected  at  the  right  time  and  is  supposed  to  be  an  
important  underestimated  electrolyte  abnormality  especially   in  the  
intensive  care  unit  setting. Sepsis  is  an  independent  risk  factor  for  
developing  hypomagnesemia  during  ICU  stay  as  reported  by  Soliman et 
al5.  
The  deficiency  of  magnesium  has  been  associated  with  the  
occurrence  of  Systemic  Inflammatory  Response  Syndrome  (SIRS)10,38. 
Sepsis , which  is  SIRS  which  has  got  an  infectious  etiology  is  supposed  
to  be  associated   with  hypomagnesemia  according  to  the  research  by  
Soliman  et  al5. 
The  purpose  of  this  study  was  to  estimate  serum  magnesium  
levels  in  the  SIRS  patients  who  have  been  admitted  to  the  medical  
intensive  care  unit  and  to  assess   the  prognostic  value  of serum  
magnesium  in these  patients. 
The  study  was  done  on  50  patients  and  the  mean  age  in  this  
particular  study  was  42.92  +  16.69  yrs .Most  of  the  patients  in  the  
study  was  in the     age  group  0f  21-40  yrs  and  the  least  number  were  in  
the  age  group  less than  20  yrs. 
In  the  study  35  patients  (70%)  were  males  and  15  were  
female(30%). The  association  between  magnesium  deficiency  and  
mortality  rate  and  clinical  improvement  while  in  ICU  was   dealt  upon  
mainly  in  this  study.  
Several  previous  studies   on  critically  ill  adults  and  children  have   
shown  the  association  of  hypomagnesemia  and  increased   occurrence  of  
mortality, increased  morbidity  ,increased  duration  of  ICU  and  hospital   
stay  and  increased  duration  of  mechanical  ventilation  . 
In  this  study which  was  done  on  50  patients  admitted  to  the  
intensive  care  unit  hypomagnesemia  was  found  in 66 %  patients and  
hypermagnesemia  was  found  in  6  %  patients. Magnesium  depletion  is  
associated  with  increased  release  of  proinflammatory  cytokines  as  in  
inflammatory  states  and  in  sepsis9. 
The  previous  studies  have  measured  the  total  serum  magnesium  
and  the  prevalence  of  hypomagnesemia   was  in  the  range  of  14  to  70  
%3,37. The  prevalence  of  magnesium deficiency    in  seriously ill  patients  in   
a study  done  by  Mousavi  et al  in Tehran,  Iran  was  33 %  and  in  the  
same  study  13.2%  patients  had  hypermagnesemia36. There   has  been  
studies  which  show  that  the  prevalence  of  hypomagnesemia  varies  from   
14  to  66  %.. Abnormal  levels  of  magnesium  has  been found  in several  
previous  studies  which  were  done  on  critically  ill  adult  patients  and  
children . 
Hypermagnesemia  is  usually  rarer  compared  to  hypomagnesemia  
and  in  this  study 6 %  of  the  patients  had  hypermagnesemia37. Previous  
studies   have  shown  that  it  was  in  the  range  of  4-  14  %37.  Musavi  et  al  
have  reported  13.2  %  incidence  of  hypermagnesemia  in  the  study  
conducted in  Tehran36. Hypermagnesemia  though  it  is  rare  has  been  found  
to  be  associated  with  increased  mortality and  morbidity  in critically  ill 
patients. The  release  of  magnesium  after  cell injury  or cell death  into  the  
extracellular  fluid  may be  the explanation  for  this  phenomenon. 
The  association  between  serum  magnesium  levels  and  mortality  
while  in  the  intensive  care  unit  was  an  important  aspect  of  this  study. 
In  this  study  in  patients  with  hypomagnesemia  the  mortality  rate  
was  81.8  %  and  in  patients  with normal  serum  magnesium  levels  the  
mortality  rate  was  found  in  this  study  to  be  14.3  %  and  was  found  to  
be  statistically  significant. The  association  between  magnesium  levels  and  
mortality  rate  has  been  found  to  vary  in  different  studies1,2,6,17. Also 
magnesium  supplementation  may  be  beneficial  in  lowering  the  mortality  
rate. 
In  the  study  conducted  by Soliman  et  al  it  was found  that  there  
was  increased  mortality  rate  in  the setting  of   hypomagnesemia   occurring  
in   the  intensive  care  unit5.In  the  study  conducted   by  Guerin et al it was  
found  that  there  was  no  difference  in  ICU  mortality  between  patients  
with  hypomagnesemia  and  patients  with  normal  serum   magnesium  
levels2. 
There  was  higher  mortality  among  patients  with   higher  than  
normal  serum  magnesium  levels  according  to  the  study  done  by  Guerin  
et  al2.  
In the  study  done  by  Chernow  et  al  a  higher  mortality  rate (41  %  
vs  13  %)  was  significantly  found  in  patients  with  magnesium  deficiency  
as  against  patients  with  normal  serum  magnesium  levels17.  Similar  results  
were  found  in  studies  done  by  Safavi  et  al  and  Rubiez  et  al1,6. 
The  higher  mortality  rate   in  patients   with  hypomagnesemia  may  
be  due  to  multiple  other   factors  also  like  cardiac  rhythm  disturbances 
and  hypokalemia37. Also the  association  of  hypomagnesemia   with  sepsis  
and SIRS  may  be  another  cause  for  the  observed  increased  mortality  rate  
in  the  study. Deheinzelin et al had reported on the outcome of seriously ill 
cancer patients with relation to serum magnesium levels in a study4.The  study  
which   has been  done  here   mainly  focusses on  the  seriously   ill  SIRS  
patients  who  have  been  admitted  to  the  ICU .   
The  difference  in  the  duration  of  ICU  stay  was  studied  and  it  was  
found  that  in  the  patients  with  low  magnesium  levels  the mean duration  
of  ICU  stay  was  5.424  , in  the  normomagnesemia  group  it  was  5.286. 
The  hypermagnesemia  group  had  mean  duration  of  ICU  stay  of  5.333. 
The  difference  was  not  found  to  be  statistically  significant  in  this  study.  
Soliman  et  al  had  reported  that  that  there  was  no  difference   in  
the  duration  of  stay  in  the   intensive  care  unit  among  the  three  different  
groups  mentioned  above5. However  patients  who  developed   magnesium  
depletion  while staying  in  the  ICU  were  found  to  have  more   duration  of  
stay  there 5. 
The  duration  of  stay  in  the  ICU  was  found  to  be  a  risk  factor  for  
developing  hypomagnesemia  and  its  complications  in other  studies . 
Hypomagnesemia  patients  had  longer  length  of  mechanical  ventilation  
and  ICU  stay  according  to  Musavi  et al 36.  
Magnesium   depletion  in  the  extracellular fluid  has  been  associated  
with  respiratory  muscle  weakness  and  respiratory  failure  and  this  later  
leads  on  to  difficulty  in  weaning  a  patient  from  the  ventilator9. The  
present  study  showed   that  the  patients  with  hypomagnesemia  needed  
mechanical  ventilation  more  than  the  patients  with  normomagnesemia.  
Prolonged  mechanical  ventilator  dependence  has  been  reported  in  
hypomagnesemia  patients  in  previous  studies28 . In  this  study  duration  of  
mechanical  ventilation  was  significantly  more  in  the  hypomagnesemia  
group  than  in  the  patients  with  normal  serum  magnesium  levels. 
Fiaccordori  et al  in  his  study  had  shown  that  patients  with  
hypomagnesemia  needed  ventilator  support  for  more  days28.It was 
researched and reported  by Molloy et al that on administering magnesium to 
patients who had hypomagnesemia ,weakness of the muscles of respiration 
improved when compared to the normomagnesemic controls29.   
Safavi  et al  had  also  reported  that  in  patients  with  
hypomagnesemia  mechanical  ventilation  duration  was  longer  than  in  
normomagnesemia  group6. In  a  study  done  by  Munoz  et  al it  was  found  
that  in  neonatal  intensive  care  unit  the  neonates  needed  ventilator  
support  more  frequently  if  they  were  in  the  hypomagnesemia  group  than  
in  the  normomagnesemic  group12,30. Also there have been several national 
studies done touching on the topic of magnesium levels and prognosis of the 
pediatric patients7,8. 
Magnesium  depletion  also  has  been  found  to  be  associated  with  
diabetes  mellitus  and is  supposed  to  be  due  to  depletion by the renal route  
that  usually  occurs  along  with  glycosuria37. 
Hypomagnesemia   has  been  associated  with  development  of  insulin  
resistance  and   a strong  relation  has  been  found  between  magnesium  
deficiency  and  Diabetes  .Specific  tubular  defect  in  the  thick  ascending  
limb  of  loop  of  henle  has  been  found  which  is  associated  with  the  
reabsorption  of  magnesium  ion  and  it  has  been   researched  and  reported  
recently.  
Increased  urinary  magnesium  excretion  due  to  hyperglycemia  and 
osmotic  diuresis  may  contribute  to  hypomagnesemia  in  diabetes34. Serum  
levels  of  magnesium  have  been  found  by  several  investigators to  
correlate  inversely  with  fasting  blood  glucose  concentration  and  the 
percentage  of  HbA1C.In  the  present  study  it  was  found  that  36.3%  of  
the  patients in  the   hypomagnesemia  group  were   diabetics and  42.8%  in  
the  normo magnesemia  group  were  diabetics. One  patient  in  the  
hypermagnesemia  group  was  found  to  be  diabetic. The  association  
between  diabetes  and  magnesium  deficiency  was  not  found  to  be  
statistically  significant  in  the  present  study. 
In  the  study  done  by  Rodriguez  et  al  it  was  found  out that 
magnesium  supplementation  can  lead  on  to  decreased  insulin  
requirements35. Another  study  done  by  Chernow  et  al  has  stressed  on  the  
point   that  magnesium  supplementation  can lead  on  to  better  glycemic  
control17 . 
Hypomagnesemia has been found to be associated with  hypertension. 
The  study  done  by Kawano  et  al  had  shed  light  on  the  association  
between  hypertension  and  magnesium  deficiency36. The  above  mentioned  
study  had  studied  the  effect  of  magnesium  supplementation  in   
hypertensive  patients36. 
In  the  present  study  it  was found  that  33.3 %  of  patients  in  the  
hypomagnesemia  group  were  hypertensives. 35.7%  patients  in  the  
normomagnesemia  group  were  hypertensive  individuals .The  association  
between  hypertension  and  magnesium  levels  were  not  found  to  be  
statistically  significant. In  the  study  done  by  Safavi  et  al  it  was  found  
that  association  between  hypomagnesemia  and  hypertension is  poor. 
The  effect  of  magnesium  supplementation  on  control  of   
hypertension  has  not    shown  a  consistent  relationship. Hypomagnesemia  
increases  arteriolar  tone  and  thus  tissue   hyperperfusion which  is  
supposed  to  be  a  homoeostatic  function  is  affected.The  failure  of  this  
homeostatic  function  leads  on  to  hypoperfusion  states which  leads  on  to  
end  organ damage in  the  brain  and   the  cardiovascular  system.     
Hypomagnesemia  has  also   been  found  to  be  associated  with  many  
other  electrolyte  abnormalities9,15,23. It  was  the  study  by  Whang  et  al  
which  reported  that  hypomagnesemia  was  seen  in  42  %  patients  with  
hypokalemia, 27%  patients  with  hyponatremia, 22 %  patients  with  
hypocalcemia  and  29%  patients  with  hypophosphatemia21,22. Serum sodium  
and   potassium  levels  were  also  estimated  in the  study . 
In  the  present  study  it  was  found  that  hypokalemia  was seen  in  
39.3%  of  the  patients  with  hypomagnesemia.71.4 %  of  the  patients  in 
normomagnesemia  group had  hypokalemia. The  difference  in the  2  groups  
were  not  found  to  be  statistically  significant. 
The  relevance  of  hypokalemia  in  the setting  of  hypomagnesemia  in  
a critically  ill  SIRS  patient  is that  hypokalemia  will  not  respond  to  
supplementation  unless  magnesium   depletion  in   the  extracellular  space  
is  detected   and  corrected  promptly. It  may  be  due  to  the  fact  that  there  
is  increased  loss  of  potassium  through  the  kidneys  in this  condition  and  
also the  membrane  ATPase  function  is  defective.  
Also there  can be  underlying  diseases  causing  deficiency  of  both  
the  electrolytes  and  associated  with  diuretic  therapy  ,diarrhea  and  
vomiting.  In  the   present  study  the  association  between  hypokalemia  and   
hypomagnesemia  was  not  significant. 
The  association  between  hyponatremia  and  hypomagnesemia  has  
been reported  in  previous  studies. Safavi  et  al  had  reported  this  
association  in a  study  done  in  Isfahan, Iran.In the present study 
hyponatremia  was  seen  in  45.4%  of  the  patients  in  the  hypomagnesemia  
group. 54.6 % of  the  patients had  serum  sodium  levels above  the  lower  
limit. 
 Hyponatremia  was  seen  in  50  %  of  the  patients  in  the  
normomagnesemia  group.Two  patients  in  the  hypermagnesemia  group  had  
hyponatremia.   
In  the  present  study  the  association  between  hyponatremia  and  
hypomagnesemia  was  not  found  to  be  statistically  significant. 
In the study the mean serum bilirubin value obtained was 1.042 mg/dl.  
Also serum creatinine had a mean value of 1.2 mg/dl. In the study,leucocytosis 
was found in 54 %  cases and  leucopenia was seen in 14%.  
 
 
 
 
SUMMARY 
The present study was done with the important purpose of ascertaining 
whether serum magnesium levels had any prognostic significance in patients 
who are diagnosed as systemic inflammatory response syndrome .The study 
was done in the seriously ill patients in the critical care unit. The inference 
from the study was that magnesium depletion was found to be associated with 
significant greater mortality rate (with  p value 0.037).Also the patients in the 
hypomagnesemia set  had more incidence of being put on mechanical 
ventilator support due to respiratory system decompensation. (p value <0.001) 
The duration of being on ventilator support was also significantly more in the 
patients with hypomagnesemia in the present study than in those who had 
normal serum magnesium concentrations.(p value <0.001). The number of 
days spent in ICU was also compared and it was found out that there was no 
significant difference in the hypomagnesemia and normomagnesemia groups 
(p value 0.865). 
There was no significant association of hypomagnesemia and other 
electrolyte abnormalities like hyponatremia and hypokalemia in the present 
study. Also the association between magnesium levels and chronic disease 
states like Diabetes mellitus and hypertension were not significant. 
                                                                 
CONCLUSION 
1. Serum magnesium levels have prognostic value in the patients 
diagnosed as SIRS in the ICU setting. 
2. Serum magnesium concentration shows association with increased 
mortality rate in the critical care unit. 
3. There is significant greater need for mechanical ventilation and 
increased duration of stay under ventilator support in the patients with 
lower magnesium levels. 
4. The duration of ICU treatment was not significantly related with the 
serum magnesium concentration. 
5. No significant association between hypomagnesemia and systemic 
hypertension could be reported. 
6. No significant association between magnesium deficiency and Diabetes 
mellitus could be found out in this study. 
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LIST OF ABBREVIATIONS 
SIRS                Systemic Inflammatory Response Syndrome 
ATP                 Adenosine Triphosphate 
WBC                White Blood Cell 
ILD                  Interstitial Lung Disease 
OPC                 Organophosphorus Compound 
ICU                  Intensive Care Unit 
PCT                  Proximal Convoluted Tubule 
DCT                 Distal Convoluted Tubule 
ECF                  Extracellular Fluid 
EGF                  Epidermal Growth Factor 
ATN                 Acute Tubular Necrosis 
CSF                  Colony Stimulating Factor 
SIADH             Syndrome of Inappropriate Antidiuretic Hormone 
TPN                  Total Parenteral Nutrition 
GFR                 Glomerular Filtration Rate 
PTH                  Parathormone 
MODS             Multiple Organ Dysfunction Syndrome 
PAI-1               Plasminogen Activator Inhibitor -1 
APC                 Activated Protein C 
DIC                  Disseminated Intravascular Coagulation 
ARDS              Acute Respiratory Distress Syndrome 
DNA                Deoxyribonucleic Acid. 
EDTA              Ethylene Diamine Tetra acetic Acid 
PROFORMA 
  
Serial No: 
  Patient Details 
          Name: 
         Hospital IP no: 
         Age: 
         Sex: 
        Address: 
        Date of admission: 
 H/o presenting illness: 
fever 
breathlessness 
symptoms relevant to the illness 
duration of ICU stay 
Past History: 
Diabetes mellitus 
Hypertension 
Ischemic heart disease 
Chronic kidney disease 
Pulmonary tuberculosis. 
h/o Malabsorption or  chronic diarrhea 
 Drug history:  
h/o diuretic drug use 
H/o magnesium supplementation 
Use of magnesium containing antacids. 
Personal History: 
Alcohol consumption 
/smoking 
 Examination: 
General Examination 
Level of consciousness and orientation 
Pallor /icterus /cyanosis 
Clubbing /lymphadenopathy/pedal edema. 
Vital parameters: 
Pulse rate : 
Heart rate: 
Blood pressure: 
Respiratory rate: 
Temperature : 
 
 
System examination: 
Cardiovascular system 
Respiratory  system 
Central  Nervous System 
Abdomen 
Investigations: 
1. Blood Urea and Serum creatinine  
2.serum magnesium 
3.serum sodium 
4.serum potassium 
5.total leucocyte count 
6.differential leucocyte count. 
7.serum bilirubin. 
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1  KANNAIYYA  64474  45  M  100 30  101  YES  NO  YES  NO  124  3  1.5  7  NO  NO  YES 1.5 1.2
2  MUTHU  62215  72  M  102 28  102  YES  NO  YES  YES 135  4  1.6  10  NO  NO  NO  0.9 1 
3  THANKAM  62236  27  F  122 26  100.6 YES  NO  NO  NO  127  3.5  1.2  5  YES 3  YES 1  1.4
4  AMIR   65226  38  M  90  24  101  YES  NO  NO  NO  135  3.4  3.2  2  NO  NO  NO  1  2 
5  ARUMUGAM  60845  47  M  96  32  100.4 YES  NO  YES  YES 136  3.5  1  5  YES 3  YES 1.4 0.9
6  THANGAMANI  59078  42  M  96  30  102  NO  NO  YES  YES 126  3.5  1.1  8  YES 8  YES 1  1.5
7  PANDISELVI  62378  55  F  98  36  101  YES  NO  NO  YES 133  3.6  1.2  10  YES 10  YES 1  1 
8  SIVANANDI  57435  28  M  96  26  101  NO  NO  NO  NO  136  3.5  1.1  5  NO  NO  NO  1.2 1 
9  RAMALINGAM  56743  65  M  102 28  102  YES  NO  YES  YES 134  3.7  1  9  YES 9  YES 0.9 1.1
10  REVATHI  62254  14  F  112 30  101  NO  YES  NO  NO  130  3.4  1.2  3  NO  NO  YES 1.2 1 
11  CHANDRAN  55902  45  M  108 24  101  NO  YES  NO  NO  135  3.4  2.5  3  NO  NO  NO  1  2.2
12  PONNAPPAN  62287  23  M  104 26  101  NO  YES  NO  NO  126  3.5  1.9  3  NO  NO  NO  1.2 1 
13  MANOJ  54322  26  M  112 28  102  NO  NO  NO  NO  133  3  1.5  5  NO  NO  NO  1.3 0.8
14  SIVARAJ  57345  17  M  96  26  102  YES  NO  NO  NO  133  3  1  10  YES 10  YES 1  1 
15  SRINIVASAN  71929  45  M  98  28  104  YES  NO  NO  NO  136  3.5  0.8  2  YES 2  YES 1  1 
16  VELAPPAN  56789  25  M  100 28  102  NO  NO  NO  NO  134  3.7  1.2  6  YES 3  YES 1  1 
17  KARUPPU  58769  40  M  104 30  101  YES  NO  YES  NO  138  3  2  1  NO  NO  NO  0.9 1 
18  KARTHICK  56430  72  M  110 26  100.8 YES  NO  YES  YES 136  3.5  0.9  4  YES 4  YES 0.9 1 
19  BALU  67553  31  M  106 28  101  NO  NO  NO  NO  137  3.4  4.6  6  NO  NO  NO  1  1.3
20  GURUSAMI  67549  66  M  114 24  101  NO  YES  YES  NO  125  3.8  0.9  5  NO  NO  YES 1  1 
21  NATHAN  55772  34  M  100 26  102  NO  NO  NO  NO  133  3.5  1  3  YES 3  YES 1  1 
22  SRUTHI  65421  40  F  102 32  101  YES  NO  YES  NO  126  3.2  5.5  8  NO  NO  NO  1  1.3
23  FAREED  65476  24  M  116 36  101  NO  NO  NO  NO  133  3.6  1.1  5  NO  NO  NO  0.9 0.7
24  PONNAIYASAMY  67009  20  M  118 30  102  YES  NO  NO  NO  135  3.8  1  6  YES 3  YES 0.9 1 
25  BALAN  62430  25  M  114 26  101  YES  NO  NO  NO  137  4  1.1  10  YES 10  YES 1  0.8
26  MALATHI  67892  52  F  100 28  101  YES  NO  NO  NO  133  3.9  2  5  NO  NO  NO  1  1 
27  PONNAMMA  57333  34  F  102 30  100.6 YES  NO  YES  NO  138  4  1.2  6  YES 4  YES 1  1.4
28  GOPALAN  67778  38  M  106 32  101  YES  NO  NO  NO  132  3.5  2.1  3  NO  NO  NO  1.5 2.3
29  PUSHPAM  60098  65  F  116 28  101  NO  NO  YES  YES 137  3.8  1.8  9  NO  NO  NO  1  1.3
30  MARISAMI  69879  56  M  102 26  102  YES  NO  YES  YES 136  3.6  1  4  YES 2  YES 0.9 1.2
31  CHINNAIYA  50088  44  M  106 32  101  YES  NO  YES  YES 124  3.9  1  7  YES 6  YES 1  1 
32  SETHU  67871  45  M  100 36  102  NO  NO  NO  NO  137  3.5  1.1  3  YES 3  YES 1  0.9
33  KAALI  55667  79  F  110 32  100.4 NO  NO  YES  YES 140  4.1  1.1  6  YES 4  YES 0.8 0.9
34  SUMITHAN  68000  56  M  104 30  101  YES  NO  NO  YES 141  4.1  2.5  7  NO  NO  NO  1  1.8
35  PRAVEEN  67001  42  M  100 24  102  YES  NO  NO  NO  142  4  0.9  2  NO  NO  NO  1.1 1.3
36  KRISHNAMMA  60001  29  F  98  26  102  YES  NO  NO  NO  136  3.4  0.8  3  NO  NO  NO  1.2 1 
37  CHELLAM  65000  30  F  96  28  101  NO  YES  NO  NO  134  4.2  0.9  5  YES 4  YES 1  1 
38  HARISAMY  64426  70  M  98  30  101  NO  NO  YES  YES 135  4.2  1.1  2  YES 2  YES 1  1 
39  SEETHA  60032  56  F  100 24  101  NO  NO  YES  YES 138  4  1.5  6  YES 2  YES 0.9 1 
40  AJITH  56010  37  M  104 32  102  YES  NO  NO  NO  139  3.8  1.1  2  YES 2  YES 0.8 1.2
41  MANI  64499  63  M  104 32  102  NO  YES  YES  YES 130  3.4  1  4  YES 3  YES 1.2 1.2
42  ANISH  67721  33  M  106 30  101  NO  NO  NO  NO  138  3.6  1.1  11  YES 8  YES 0.8 1.4
43  PONNAYAN  54999  39  M  94  28  101  YES  NO  NO  NO  133  3.6  1.8  5  NO  NO  NO  1  3 
44  LAKSHMANAN  66661  26  M  96  26  101  YES  NO  NO  NO  138  3.7  1  6  YES 3  YES 1  1 
45  KANTHI  55555  32  F  100 28  102  NO  YES  NO  NO  142  4.3  1  8  NO  NO  YES 0.9 0.9
46  NARAYANAN  66605  59  M  102 26  101  NO  NO  YES  YES 138  3.6  1.1  7  NO  NO  YES 1  0.7
47  REEMA  67713  21  F  106 28  102  YES  NO  NO  NO  136  3  0.9  4  YES 2  NO  1.2 0.9
48  RAJU  68888  48  M  108 24  101  NO  NO  YES  YES 138  3.8  1.7  5  NO  NO  NO  1.4 2.1
49  MANIYAMMA  60003  73  F  102 30  102  NO  NO  NO  NO  141  3.7  1.2  3  YES 3  NO  1.2 1.3
50  RAJAMMA  62222  53  F  100 28  101  YES  NO  NO  NO  133  3.9  2  5  NO  NO  NO  1  1 
 
 
 
 
 
 
 
  
  
  
 
  
 
 
 
 
 
 
 
 
 
